A Prospective, Randomized, Assessor-Blinded, Multicenter Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve Reconstruction
Part of paid clinical trials in Indianapolis, Indiana.
- Sponsor
- Axogen Corporation
- Study ID
- NCT07657182
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Mixed Peripheral Nerve Injury
- Motor Peripheral Nerve Injury
- Peripheral Nerve Discontinuity
- Peripheral Nerve Injury
- Upper Extremity Nerve Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Avance Nerve Graft — BIOLOGICALA commercially available, sterile, single-use peripheral nerve scaffold indicated for the treatment of functional deficits, manufactured from decellularized and sterilized extracellular matrix derived from human peripheral nerve tissue.
- Sural nerve autograft — PROCEDUREA patient's own peripheral nerve tissue harvested in a secondary surgical procedure of the lower extremity where a functioning sural nerve is sacrificed for use in the reconstruction of a nerve defect.
Study Details
This is a multicenter, 1:1 randomized, prospective, comparative study in participants requiring reconstruction of a mixed or motor nerve in the upper extremity. This study will consist of a screening visit, an operative visit, and 9 post-operative follow-up visits at Week 4, and Months 3, 6, 9, 12, 15, 18, 21, and 24.
Key Dates
- Start date
- Jun 12, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 5, 2030
- Completion
- Dec 5, 2030
Study Design
- Enrollment
- 178 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Avance Nerve GraftStudy Treatment: Avance Nerve Graft repairs of mixed or motor nerves (\> 25 mm gaps)
- Active Comparator: Sural nerve autograftComparator: Sural nerve autograft repairs of mixed or motor nerves (\> 25 mm gaps)
Primary Outcome Measure
Recovery of motor function [ Time Frame: Assessed at 24 months ]
Central Contacts
- Stacy Arnold(386) 462-6800
- Hayley Nicolosi(386) 462-6800
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| OrthoIndy | Indianapolis | Indiana | 46260 | Brandon Smetana, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Indianapolis, IN
By research site
Related Studies
- Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)PHASE1 · Recruiting · W. Dalton Dietrich · Miami, Florida
- 4-AP Peripheral Nerve Crossover TrialPHASE2 · Recruiting · University of Arizona · Tucson, Arizona